Gold prices cool after hitting over 2-week high on Fed independence fears
On Friday, Truist Securities initiated coverage on Waystar Holding (NASDAQ:WAY) with a Buy rating and set a price target of $45.00. Currently trading at $35.27, Waystar’s stock has shown impressive momentum with a 70% return over the past year. The firm’s analysts noted that Waystar is poised to benefit from the current evolution in healthcare payments workflow, where there is an increasing demand for automated software solutions to reduce administrative burdens and enhance efficiency. According to InvestingPro data, the company maintains strong liquidity with a current ratio of 2.55.
Waystar’s multifaceted growth strategy has been highlighted as a key factor that has enabled the company to outpace the provider software solutions market for nearly a decade, demonstrated by its robust revenue growth of 19.28% in the last twelve months. The analysts at Truist Securities expressed confidence in Waystar’s ability to continue this trend, citing the company’s conservative approach to its 2025 guidance. InvestingPro analysis reveals 5 analysts have revised their earnings upwards for the upcoming period.
The initiation of coverage comes with the belief that Waystar’s performance will likely lead to another year of exceeding expectations and upward adjustments, commonly referred to as ’Beat and Raise’ quarters. The analysts underscored the potential for Waystar to surpass its targets, based on the company’s historical growth pattern and strategic positioning within the industry.
The $45 price target reflects Truist Securities’ positive outlook on Waystar’s future performance, with analyst targets ranging from $45 to $55, suggesting potential upside. While the company isn’t currently profitable, analysts expect positive earnings this year with an EPS forecast of $1.40 for FY2025. Waystar’s stock is expected to be influenced by the company’s ability to capitalize on these industry trends and deliver on its financial goals. For deeper insights into Waystar’s valuation and growth prospects, investors can access comprehensive analysis through InvestingPro, which offers exclusive financial metrics and expert research reports.
Truist Securities’ coverage of Waystar aligns with a broader industry focus on innovation and efficiency in healthcare payment processes. Waystar’s emphasis on automation and software solutions positions the company at the forefront of this transformation, which is a significant factor in the firm’s Buy rating and optimistic price target.
In other recent news, Waystar has introduced its Auth Accelerate solution, designed to streamline healthcare authorizations, reducing processing times by 70% and achieving an 85% auto-approval rate for clients. This development is seen as a significant advancement in addressing prior authorization bottlenecks in healthcare. In financial updates, Waystar’s performance has been robust, with Goldman Sachs reporting the company exceeded fourth-quarter 2024 revenue and profitability estimates by over $10 million and $5 million, respectively. Both Goldman Sachs and Evercore ISI have raised their price targets for Waystar shares, to $52 and $50, respectively, while maintaining Buy and Outperform ratings. Canaccord Genuity also raised its price target to $50, citing Waystar’s significant growth and successful client retention strategies.
Meanwhile, Waystar announced a public offering of 18 million shares by investment funds affiliated with EQT AB (ST:EQTAB), Canada Pension Plan Investment Board, and Bain Capital, LP. The offering, led by J.P. Morgan, Goldman Sachs, and Barclays (LON:BARC), will not provide financial benefits to Waystar, as proceeds go to the selling stockholders. Analysts from Evercore ISI highlighted Waystar’s consistent post-IPO performance and noted potential growth from the Change Healthcare (NASDAQ:CHNG) acquisition disruption. The company’s improved financial health, with a leverage ratio of approximately 2.8 times, offers flexibility for future investments. These developments indicate a period of strategic growth and market positioning for Waystar.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.